Lepu Scientech Medical Technology's Profit Edges Lower in 2025; Shares Fall 9%

MT Newswires Live

Mar 31

Lepu Scientech Medical Technology's (HKG:2291) net profit attributable to shareholders fell 2.4% to 239.7 million yuan for 2025, from 245.6 million yuan a year earlier, according to a Monday Hong Kong bourse filing.

Shares of the firm were down over 9% in Tuesday's late-morning trade.

Earnings per share came in at 0.69 yuan, compared with 0.71 yuan a year earlier.

Revenue rose 12% to 527.9 million yuan from 471.6 million yuan in 2024.

The board recommended a final dividend of 0.50 yuan per share, subject to shareholder approval.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2623729253"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2623729253\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2623729253?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-03-31 12:18","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2623729253","market":"nz","top_or_hot":-1,"title":"Lepu Scientech Medical Technology's Profit Edges Lower in 2025; Shares Fall 9%","media":"MT Newswires Live","content":"<html><body><p> Lepu Scientech Medical Technology's (HKG:2291) net profit attributable to shareholders fell 2.4% to 239.7 million yuan for 2025, from 245.6 million yuan a year earlier, according to a Monday Hong Kong bourse filing.</p><p>Shares of the firm were down over 9% in Tuesday's late-morning trade.</p><p>Earnings per share came in at 0.69 yuan, compared with 0.71 yuan a year earlier.</p><p>Revenue rose 12% to 527.9 million yuan from 471.6 million yuan in 2024.</p><p>The board recommended a final dividend of 0.50 yuan per share, subject to shareholder approval.</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Lepu Scientech Medical Technology's Profit Edges Lower in 2025; Shares Fall 9%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nLepu Scientech Medical Technology's Profit Edges Lower in 2025; Shares Fall 9%\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2026-03-31 12:18</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> Lepu Scientech Medical Technology's (HKG:2291) net profit attributable to shareholders fell 2.4% to 239.7 million yuan for 2025, from 245.6 million yuan a year earlier, according to a Monday Hong Kong bourse filing.</p><p>Shares of the firm were down over 9% in Tuesday's late-morning trade.</p><p>Earnings per share came in at 0.69 yuan, compared with 0.71 yuan a year earlier.</p><p>Revenue rose 12% to 527.9 million yuan from 471.6 million yuan in 2024.</p><p>The board recommended a final dividend of 0.50 yuan per share, subject to shareholder approval.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK1100","symbol_name":"医疗保健设备","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2623729253","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2623729253","pubTimestamp":1774930691,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Lepu Scientech Medical Technology's  net profit attributable to shareholders fell 2.4% to 239.7 million yuan for 2025, from 245.6 million yuan a year earlier, according to a Monday Hong Kong bourse filing.Shares of the firm were down over 9% in Tuesday's late-morning trade.Earnings per share came in at 0.69 yuan, compared with 0.71 yuan a year earlier.Revenue rose 12% to 527.9 million yuan from 471.6 million yuan in 2024.The board recommended a final dividend of 0.50 yuan per share, subject to shareholder approval.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK1100":"医疗保健设备","02291":"心泰医疗"},"translate_title":"乐普科技医疗科技2025年利润小幅下降；股价下跌9%","themeId":"f6f7c9f6a0174df79daf9f1dfd21f836","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02291":1},"content_text":"Lepu Scientech Medical Technology's (HKG:2291) net profit attributable to shareholders fell 2.4% to 239.7 million yuan for 2025, from 245.6 million yuan a year earlier, according to a Monday Hong Kong bourse filing.Shares of the firm were down over 9% in Tuesday's late-morning trade.Earnings per share came in at 0.69 yuan, compared with 0.71 yuan a year earlier.Revenue rose 12% to 527.9 million yuan from 471.6 million yuan in 2024.The board recommended a final dividend of 0.50 yuan per share, subject to shareholder approval.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}